Literature DB >> 21346095

Testosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older men.

Tung Wai Auyeung1, Jenny Shun Wah Lee, Timothy Kwok, Jason Leung, Claes Ohlsson, Liesbeth Vandenput, Ping Chung Leung, Jean Woo.   

Abstract

OBJECTIVE: To examine the relationship between different measures of testosterone and estradiol (E(2)), muscle mass, muscle strength, and physical performance; and to test whether the association of sex hormone level with muscle strength and physical performance was independent of muscle mass. DESIGN AND METHODS: A cross-sectional survey on 1489 community-dwelling men older than 64 years of age. Serum levels of testosterone and E(2) were measured by mass spectrometry, and sex hormone-binding globulin (SHBG) levels were measured by immunoradioassay. Muscle mass was examined by dual-energy X-ray absorptiometry and physical performance was assessed by hand-grip strength, gait speed, step length and chair-stand test.
RESULTS: Appendicular skeletal mass (ASM) was positively associated with total testosterone (TT; P<0.001), free testosterone (FT; P<0.001), and total E(2) (P<0.001) but not with free E(2) (P=0.102). After adjustment for age, serum SHBG and relative ASM, both TT and FT were significantly associated with grip strength, narrow-walk speed and the composite neuromuscular score. Higher total E(2), but not free E(2) was associated with lower grip strength (P<0.05) after adjustment for age, FT, SHBG and relative ASM.
CONCLUSIONS: Testosterone level was related to both muscle mass, strength and physical performance. Total E(2) level, though related to muscle mass positively, affected muscle strength adversely in older men.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346095     DOI: 10.1530/EJE-10-0952

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  25 in total

1.  Ultrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry.

Authors:  Qingqing Wang; Kannan Rangiah; Clementina Mesaros; Nathaniel W Snyder; Anil Vachani; Haifeng Song; Ian A Blair
Journal:  Steroids       Date:  2015-01-29       Impact factor: 2.668

2.  Androgenic and estrogenic regulation of Atrogin-1, MuRF1 and myostatin expression in different muscle types of male mice.

Authors:  H De Naeyer; S Lamon; A P Russell; I Everaert; A De Spaey; B Vanheel; Y Taes; W Derave
Journal:  Eur J Appl Physiol       Date:  2014-01-05       Impact factor: 3.078

Review 3.  Aging, hormones and receptors.

Authors:  M Hill; Z Třískala; P Honců; M Krejčí; J Kajzar; M Bičíková; L Ondřejíková; D Jandová; I Sterzl
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

Review 4.  Challenges to the measurement of estradiol: an endocrine society position statement.

Authors:  William Rosner; Susan E Hankinson; Patrick M Sluss; Hubert W Vesper; Margaret E Wierman
Journal:  J Clin Endocrinol Metab       Date:  2013-03-05       Impact factor: 5.958

5.  Circulating Estrogen Levels and Self-Reported Health and Mobility Limitation in Community-Dwelling Men of the Framingham Heart Study.

Authors:  Guneet Kaur Jasuja; Thomas G Travison; Joanne M Murabito; Maithili N Davda; Adam J Rose; Shehzad Basaria; Andrea Coviello; Ramachandran S Vasan; Ralph D'Agostino; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-08-01       Impact factor: 6.053

Review 6.  Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence.

Authors:  Kitty Kit Ting Cheung; Andrea On Yan Luk; Wing Yee So; Ronald Ching Wan Ma; Alice Pik Shan Kong; Francis Chun Chung Chow; Juliana Chung Ngor Chan
Journal:  J Diabetes Investig       Date:  2014-11-03       Impact factor: 4.232

7.  Endocrine determinants of incident sarcopenia in middle-aged and elderly European men.

Authors:  Evelien Gielen; Terence W O'Neill; Stephen R Pye; Judith E Adams; Frederick C Wu; Michaël R Laurent; Frank Claessens; Kate A Ward; Steven Boonen; Roger Bouillon; Dirk Vanderschueren; Sabine Verschueren
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-27       Impact factor: 12.910

8.  Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study.

Authors:  David Robinson; Hans Garmo; Pär Stattin; Karl Michaëlsson
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

Review 9.  Androgen effects on skeletal muscle: implications for the development and management of frailty.

Authors:  Matthew D L O'Connell; Frederick C W Wu
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

10.  Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).

Authors:  Rajib K Bhattacharya; Mohit Khera; Gary Blick; Harvey Kushner; Martin M Miner
Journal:  Clin Interv Aging       Date:  2012-08-24       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.